Ali Mofeez

668 total citations
6 papers, 495 citations indexed

About

Ali Mofeez is a scholar working on Pharmacology, Biological Psychiatry and Psychiatry and Mental health. According to data from OpenAlex, Ali Mofeez has authored 6 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 2 papers in Biological Psychiatry and 2 papers in Psychiatry and Mental health. Recurrent topics in Ali Mofeez's work include Cannabis and Cannabinoid Research (3 papers), Treatment of Major Depression (2 papers) and Tryptophan and brain disorders (2 papers). Ali Mofeez is often cited by papers focused on Cannabis and Cannabinoid Research (3 papers), Treatment of Major Depression (2 papers) and Tryptophan and brain disorders (2 papers). Ali Mofeez collaborates with scholars based in United Kingdom and United States. Ali Mofeez's co-authors include Celia J. A. Morgan, H. Valerie Curran, Brigitta Brandner, Lesley Bromley, Tom P. Freeman, Gianluca Baio, Chandni Hindocha, Rachel Lees, Paul D. Morrison and Dominic O’Ryan and has published in prestigious journals such as Neuropsychopharmacology, Psychopharmacology and The Lancet Psychiatry.

In The Last Decade

Ali Mofeez

6 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ali Mofeez United Kingdom	6	329	166	153	124	66	6	495
Jessica Hawkins United States	11	347 1.1×	158 1.0×	71 0.5×	253 2.0×	71 1.1×	19	610
Nikita N. Burke Ireland	14	209 0.6×	173 1.0×	74 0.5×	167 1.3×	99 1.5×	25	854
Brooke Short Australia	7	351 1.1×	144 0.9×	225 1.5×	286 2.3×	234 3.5×	15	843
Lejla Čolić Germany	14	176 0.5×	113 0.7×	245 1.6×	133 1.1×	113 1.7×	45	583
Marie Woelfer United States	10	141 0.4×	101 0.6×	186 1.2×	281 2.3×	72 1.1×	13	704
Diana Limoncelli United States	15	181 0.6×	265 1.6×	133 0.9×	125 1.0×	76 1.2×	20	574
Elisse Kramer United States	16	204 0.6×	187 1.1×	274 1.8×	50 0.4×	238 3.6×	26	891
Ida Fredriksson United States	15	201 0.6×	565 3.4×	154 1.0×	123 1.0×	29 0.4×	22	878
Atul Khullar Canada	9	319 1.0×	77 0.5×	134 0.9×	195 1.6×	116 1.8×	21	627
Shakila Meshkat Canada	14	277 0.8×	120 0.7×	72 0.5×	218 1.8×	113 1.7×	70	618

Countries citing papers authored by Ali Mofeez

Since Specialization

Citations

This map shows the geographic impact of Ali Mofeez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Mofeez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Mofeez more than expected).

Fields of papers citing papers by Ali Mofeez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Mofeez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Mofeez. The network helps show where Ali Mofeez may publish in the future.

Co-authorship network of co-authors of Ali Mofeez

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Mofeez. A scholar is included among the top collaborators of Ali Mofeez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Mofeez. Ali Mofeez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hindocha, Chandni, Gianluca Baio, Rachel Lees, et al.. (2023). Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational Psychiatry. 13(1). 131–131. 14 indexed citations

2.

Lees, Rachel, Lindsey A. Hines, Chandni Hindocha, et al.. (2023). Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder. Psychopharmacology. 240(2). 337–346. 13 indexed citations

3.

Freeman, Tom P., Chandni Hindocha, Gianluca Baio, et al.. (2020). Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. The Lancet Psychiatry. 7(10). 865–874. 139 indexed citations

4.

Morgan, Celia J. A., Ali Mofeez, Brigitta Brandner, Lesley Bromley, & H. Valerie Curran. (2003). Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose?response study. Psychopharmacology. -1(1). 1–1. 80 indexed citations

5.

Morgan, Celia J. A., Ali Mofeez, Brigitta Brandner, Lesley Bromley, & H. Valerie Curran. (2003). Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers. Neuropsychopharmacology. 29(1). 208–218. 212 indexed citations

6.

Renna, Maurizio, Tim Wigmore, Ali Mofeez, & C. Gillbe. (2002). Biasing Effect Of The Electromyogram On Bis: A Controlled Study During High-Dose Fentanyl Induction. Journal of Clinical Monitoring and Computing. 17(6). 377–381. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact